Literature DB >> 6104949

Selective erythroid and magakaryocytic aplasia after sulfasalazine administration.

G E Davies, J Palek.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1980        PMID： 6104949

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN： 0003-9926


× No keyword cloud information.
  4 in total

Review 1.  Sulfasalazine. Adverse effects and desensitization.

Authors:  S L Taffet; K M Das
Journal:  Dig Dis Sci       Date:  1983-09       Impact factor: 3.199

Review 2.  Comparative tolerability of treatments for inflammatory bowel disease.

Authors:  R B Stein; S B Hanauer
Journal:  Drug Saf       Date:  2000-11       Impact factor: 5.606

Review 3.  Comparative tolerability of therapies for ulcerative colitis.

Authors:  Sandro Ardizzone; Gabriele Bianchi Porro
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

4.  Thrombocytopenia due to aurothioglucose, sulphasalazine, and hydroxychloroquine.

Authors:  M J Wijnands; W A Allebes; A M Boerbooms; L B van de Putte; P L van Riel
Journal:  Ann Rheum Dis       Date:  1990-10       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.